LivingGLP1
Study S001723

Effects of Liraglutide on Endoplasmic (ER) Stress in Obese Patients With Type 2 Diabetes

Registration

Registration
NCT02344186
Study type
INTERVENTIONAL
Allocation
RANDOMIZED
Phase
PHASE4
Masking
SINGLE
Status
UNKNOWN
Enrollment
12
Start
2014-05
Primary completion
2022-12-31
Lead sponsor
Temple University
Conditions
Type 2 Diabetes
Interventions
DRUG:Liraglutide
Results posted
FALSE

Registered primary outcomes

  • Changes in unfolded protein response markers [baseline, 6 months, 9 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.